Tilray

(NASDAQ: TLRY)
Healthcare  |  Drug Manufacturers—Specialty & Generic
7.85 0.89 12.79%
Stock Price | July 6, 2020, 4 p.m.
6 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 6.96
52 Week Low: 2.43
52 Week High: 49.49
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Read more Read less

Recently Viewed Tickers

Premium Assessing Focus List Prospects Over the Balance of 2020

4 Comments
Yesterday

Premium Cannabis Stocks Review - Weekend Edition 07/06/20

4 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 07/01/20

6 Comments
6 days ago
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 06/29/20

18 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 06/22/20

21 Comments
2 weeks ago

Premium Weekly Review 06/19/20

2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 06/15/20

12 Comments
3 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 06/12/20

13 Comments
3 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 06/08/20

20 Comments
4 weeks ago